1 - 25 of 31
Number of results to display per page
TitleCreatorRelation Is Part Of
1 MS Treatment/Immune System TargetsRobert Shin, MDNANOS Annual Meeting 2023: Neuroimmunology: https://novel.utah.edu/collection/NAM/toc/
2 Decreased Vision in Multiple Sclerosis is Associated With Novel Foveal Features Visualized Using Adaptive OpticsAubrey C. Hargrave, Lakshmi Leishangthem, May Han, Lucas Kipp, Fareshta Khushzad, Jennifer Yarp, Nripun Sredar, Alfredo Dubra, Heather MossNANOS Annual Meeting 2021: Scientific Platform I
3 Therapies for Multiple SclerosisSashank Prasad, MD, Brigham and Women's HospitalNANOS 2013: Jorunal Club
4 Color Vision Deficits in Multiple Sclerosis (Video)Neda Ansari; Reza Vosoughi; Kathleen T. Mullen; Ambarish Pandey; Behzad MansouriNANOS Annual Meeting 2015 Scientific Platform Presentations (Session 1)
5 The Eye-Brain Interface in Cerebral Malaria (video)Douglas Postels, MD, MSNANOS Annual Meeting 2016: Hot Topics - Today and Tomorrow
6 MS and the Immune SystemJennifer Graves, MD, PhD, MASNANOS Annual Meeting 2023: Neuroimmunology: https://novel.utah.edu/collection/NAM/toc/
7 We Can Hardly Believe Our EyesAndrew Dugue, Scott Grossman, Nicolas Abreu, Steven Galetta, Lauren Krupp, Marc Branche, Janet Rucker, Laura Balcer, Claire Miller, Christopher William, Kimberly O'NeillNANOS Annual Meeting 2023: Walsh Society Meeting Session I: "Adventureland": Learning From Pediatric Neuro-Ophthalmic Disorders: https://novel.utah.edu/collection/NAM/toc/
8 Patient-Reported Outcome Measures in Neuro-Ophthalmic Clinical ResearchLindsey De Lott, MD, MSNANOS Annual Meeting 2022: Hot Topics
9 Classification of Functional Disorders and Role of Modern NeuroimagingJeffrey P. Staab, MD, MSNANOS Annual Meeting 2022: Functional Disorders and the Neuro-Ophthalmologist
10 The Impact of Acetylcholine Receptor Antibody Titers in Acetylcholine Receptor Antibody-Positive Ocular Myasthenia Gravis: Generalization, Presence of Thyroid Autoimmune Antibodies, and ThymomaMontana Supawongwattana; Kavin Vanikieti; Panitha Jindahra; Tanyatuth PadungkiatsagulNANOS Annual Meeting 2023: Scientific Platform Session I: https://novel.utah.edu/collection/NAM/toc/
11 New Therapies for Multiple Sclerosis, Beyond the ABCsAri J. GreenNANOS Annual Meeting Journal Club, 2015
12 New Therapies for Multiple Sclerosis, Beyond the ABCs (video)Ari J. Green, MD, University of California San FranciscoNANOS Annual Meeting Journal Club, 2015
13 Characterization of Subclinical Optic Nerve MRI Lesions in the N-Momentum TrialJeffrey Bennett; Friedemann Paul; John Chen; Michael Smith; Daniel Cimbora; Kristina Patterson; Bruce CreeNANOS Annual Meeting 2023: Scientific Platform Session III: https://novel.utah.edu/collection/NAM/toc/
14 Double Vision, Double AgainVirender Sachdeva, MS, DNBNANOS Annual Meeting 2022: Complex Cases in Pediatric Neuro-Ophthalmology: Avoiding Mimickers, Missteps, and Misdiagnosis
15 Genotype-Phenotype Correlations in Autosomal Dominant Optic AtrophyJoshua Harvey, MA, BM, BCh, FRCOphthNANOS Annual Meeting 2022: Scientific Platform III
16 Leber's Hereditary Optic Neuropathy in WomenGiulia Amore, Martina Romagnoli, Chiara La Morgia, Michele Carbonelli, Francesca Allegrini, Rustum Karanjia, Alfredo Sadun, Valerio CarellNANOS Annual Meeting 2021: Scientific Platform Session II
17 A Randomized Prospective Trial Comparing Repository Corticotropin Injection and Intravenous Methylprednisolone in Acute Optic NeuritisJeffrey Bennett, MDNANOS Annual Meeting 2022: Scientific Platform Session II
18 Sustainability of Teprotumumab Efficacy in Thyroid Eye DiseasePrem S. Subramanian, Saba Sile, Robert Holt, Raymond DouglasNANOS Annual Meeting 2022: Scientific Platform III
19 Continuous Hypoxia Reduces Retinal Ganglion Cell Degeneration in a Mouse Model of Mitochondrial Optic NeuropathySidney Gospe, MD, PhDNANOS Annual Meeting 2022: Scientific Platform III
20 In Vivo Application of Electric Fields Collaborate With rRHEB to Direct Optic Nerve RegenerationTimothy Kim; Sasha Medvidovic; Phillip Lam; Petcy Yao; Ege Iseri; Micalla Peng; Biju Thomas; Mahnaz Shahidi; Gianluca Lazzi; Kimberly GokoffskiNANOS Annual Meeting 2023: Scientific Platform Session II: https://novel.utah.edu/collection/NAM/toc/
21 Long-Term Efficacy of Satralizumab in Neuromyelitis Optica Spectrum Disorder: Results from SAkuraSky and SAkuraStarBenjamin M. Greenberg, Jerome de Seze, Albert Saiz, Takashi Yamamura, Michael Yeamen, Carole Marcillat, Xiujing Kou, Kristina Weber, Kathleen Blondeau, Brian Weinshenker, Francesco PattiNANOS Annual Meeting 2022: Scientific Platform Session II
22 Teprotumumab Efficacy in Retreatment and Longer-Term Thyroid Eye Disease: OPTIC-X Study ResultsRaymond Douglas, Saba Sile, Terry Smith, George KahalyNANOS Annual Meeting 2021: Scientific Platform I
23 VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED): Phase 1/2 Clinical Study in PatientsRaymond Douglas; Kimberley Cockerham; Roger Turbin; Rosa Tang; Navdeep Nijhawan Shoaib Ugradar; Denis O'Shaughnessy; Rochelle Summerfelt; Angela She; Barrett KatzNANOS Annual Meeting 2023: Scientific Platform Session II: https://novel.utah.edu/collection/NAM/toc/
24 Epigenetic Reprogramming- A Novel Gene Therapy to Rejuvenate Injury-Induced Dysfunction of Retinal Ganglion Cells in Optic NeuropathiesDrenushe Krasniqi; Madhura Shah; Margarete Karg; Yuancheng Lu; David Sinclair; Bruce Ksander; Joseph RizzoNANOS Annual Meeting 2023: Scientific Platform Session II: https://novel.utah.edu/collection/NAM/toc/
25 European Perspective - It Could Be MSAxel Petzold, MD, PhD, FRCP, FRCPath, FRCOphthNANOS Annual Meeting 2023: State of the Art - Global Perspectives: https://novel.utah.edu/collection/NAM/toc/
1 - 25 of 31